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Abstract
Background:  In Sweden, diabetes prevalence is increasing in spite of unchanged incidence,
indicating improved survival. In recent US studies mortality in diabetic subjects has decreased over
three decades, but only in men. Our aim was to study mortality over time in diabetic subjects.
Methods: The annual Swedish Living Conditions Survey from 1980 to 2004 has been record-linked
to the Cause of Death Register in order to study trends in mortality risk for those reporting
diabetes as a chronic illness. Survival and the relative mortality risk within 5 years of follow-up have
been calculated for a random sample of men and women aged 40–84 years with (n = 3,589) and
without diabetes (n = 85,685) for the period 1980 to 2004. Poisson regression models were used.
Results: The age-adjusted mortality risk relative to non-diabetics within 5 years of follow-up for
men was doubled during all periods. The relative risk for women was initially about 2.5, with a
substantial drop in mortality in 1995–1999 to 1.45 although it increased to 1.90 in the last period.
Using models that took into consideration the presence of heart disease, hypertension, daily
smoking, and socio-economic status at the initial interview did not change the relative mortality
risk. The age-adjusted 10-year observed survival rate for men with diabetes increased from 41.4%
1980–1984 to 51.5% in 1995–1999. The observed survival for women increased from 43.7% to
61.0%.
Conclusion: Survival rates have improved in subjects with diabetes since the early 1980s, more
so in women than in men, thereby decreasing the gap to non-diabetic women.
Background
Patients with diabetes have a markedly increased mortal-
ity which arises mainly from cardiovascular disease and
end-stage renal disease [1-3]. The classical risk factors for
cardiovascular disease, smoking, hypertension, and
hypercholesterolemia, contribute strongly to the mortal-
ity [4]. Treatment methods for diabetes focus on
improved glucose control and cardiovascular prevention.
These methods have undergone several changes during
the last decades, and international guidelines have been
established.
There is a consensus among researchers that diabetes prev-
alence is increasing. The debate is rather whether this is
due to an increasing age-specific prevalence due to an
increase in incidence or to a longer longevity among dia-
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betics [5] or whether a higher total prevalence can solely
be ascribed to an aging population. Recent Swedish pop-
ulation studies do not support a higher incidence during
the last 30 years [6,7] which corroborates pharmaco-epi-
demiological data from the Danish island of Fyn [8]. In
Sweden, a higher prevalence over time seems restricted to
the elderly [9]. Trends in all causes of death in Sweden
where diabetes is either reported as an underlying or con-
tributory cause of death show a clear sex difference, i.e. a
small increase in diabetes mortality for men, but a steady
decrease in mortality for women between 1970 and 2004
[9].
Conflicting results have been published concerning dia-
betes survival. Studies from the US and England have
shown a clear improvement in diabetes survival up to
1999 [10,11]. A recent report from the National Health
and Nutrition Examination Survey (NHANES) in the US
showed that among diabetic men all-cause mortality
decreased by more than forty percent between 1971 and
2000, accompanying the decrease in the non-diabetic
population [12]. However, among women with diabetes,
no decline in mortality was found, and that lead to a dou-
bling of the mortality rate difference between diabetic and
non-diabetic women. A recent report from the population
based HUNT study in Norway described similar improve-
ments in mortality in coronary heart disease among sub-
jects with or without diabetes between the mid 1980's and
the mid 1990's with a persistent doubled mortality risk in
diabetic subjects [13].
The aim of this study was to report trends in diabetes sur-
vival in Sweden from 1980 to 2004 and to analyse
whether these trends were different for the sexes and
whether they were influenced by changes in risk factor
patterns or by socio-economic status.
Methods
Statistics Sweden has conducted annual surveys since
1975 of the living conditions of a random sample of
about 7,000 people aged 16–84 years of age [14]. These
surveys collect individual data on health, lifestyle, social
and economic conditions, etc. It is possible to extract
information from these surveys for those reporting diabe-
tes as a chronic illness or if they regularly take medicines
for diabetes. We linked records from the Living Condi-
tions Surveys from 1980 to 2004 to corresponding records
in the national Cause of Death Register from 1980 to
2004. This allowed us to compare survival among those
reporting diabetes with survival among the rest of the sur-
vey sample (the general population) adjusting for heart
disease, hypertension, smoking, and socio-economic sta-
tus at the time of the interview (baseline). We restricted
the analysis to the age group 40–84 years at the initial
interview in order to obtain a more homogenous group of
diabetes patients, mainly patients with Type 2 diabetes.
The results presented here are based on 89,274 interviews:
Table 1 presents baseline characteristics concerning the
subjects. The average age of those reporting diabetes in the
surveys was 65 years for men and 69 years for women and
did not change over time.
We used Poisson regression models with mortality as the
dependent variable to analyse the relative mortality risk
within 5 years of follow-up among diabetics and non-dia-
betics, for 5-year time periods from 1980–1984 to 2000–
Table 1: Base-line characteristics for subjects reporting diabetes as a chronic illness in the Swedish Living Conditions Survey 1980–
2004. 
1980–1984 1985–1989 1990–1994 1995–1999 2000–2004
No % No % No No % % No %
Diabetes among population
Age 40–64 M 146 2.4 135 2.4 147 2.6 152 2.7 221 3.9
F 91 1.5 98 1.8 86 1.5 106 1.8 140 2.3
Age 65–74 M 116 5.8 120 6.3 96 5.9 106 7.1 142 9.0
F 130 5.9 126 6.0 101 5.7 130 7.8 129 7.3
Age 75–84 M 108 7.1 74 6.9 65 6.8 80 8.2 111 10.3
F 166 8.3 117 7.9 122 9.8 96 7.8 132 8.9
CHD or hypertension1 among diabetics M 151 40.8 117 35.6 94 30.5 138 40.8 227 47.9
F 214 55.3 150 44.0 132 42.7 145 43.7 219 54.6
CHD or hypertension1 among non-diabetics M 1 684 18.4 1 419 17.1 1 288 16.1 1 317 16.9 1 610 20.4
F 2 274 22.9 1 632 18.6 1 405 16.5 1 445 17.2 1 738 19.6
Daily smokers among diabetics M 101 27.3 71 21.6 69 22.4 70 20.7 73 15.4
F 42 10.9 38 11.1 29 9.4 43 13.0 54 13.5
Daily smokers among non-diabetics M 3 057 33.4 2 464 29.8 2 150 26.8 1 686 21.6 1 474 18.6
F 1 989 20.0 1 929 21.9 2 026 23.8 1 863 22.1 1 768 19.9
Number of observations (No.) and percentages (%).
1. ICD-9: 401 – 429 Hypertension and coronary heart disease.Cardiovascular Diabetology 2008, 7:32 http://www.cardiab.com/content/7/1/32
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2004. The data for men and for women were analysed sep-
arately, and we included adjustments for age, reported
heart disease and hypertension (ICD-9: 401–429), daily
smoking, and socio-economic status level at the time of
the interviews.
Results
Multivariate analyses showed that the diabetics had a
three- to four-fold higher mortality risk than non-diabet-
ics (Table 2). Adjusting the results for age of the subjects
reduced the relative risk, while adjusting for the other fac-
tors (heart disease, hypertension, smoking, and socio-eco-
nomic status) did not change the relative risk. There was
no substantial change over time in relative risk for men
with diabetes as compared with men without diabetes.
The diabetics' risk remained slightly above two through-
out the period except for a small increase during the time
period 1995–99.
The relative risk for women, adjusted for age, was 2.47 in
1980–1984, 2.77 in 1985–1989, and 2.43 in 1990–1994,
followed by a substantial drop to 1.45 in 1995–1999
(Table 2). Mortality risk increased to 1.90 in the last
cohort. After adjusting for the full model (model 4), the
1995–1999 cohort only barely differed from the non-dia-
betic population (RR 1.41; CI 1.04–1.92). On the other
hand, this period had a significantly lower relative mortal-
ity risk than the two earlier periods.
Figures 1 and 2 present long-term survival rates for men
and women in Sweden for those reporting diabetes as a
chronic illness in the surveys. For each consecutive cohort
some further improvement in survival can be discerned.
For men the most obvious improvement was for the latest
cohort and for women the latest two cohorts.
The long-range observed survival rates for diabetics
improved substantially (Table 3). Five year survival
increased from 68.4% to 80.4% in men between 1980–
1984 and 2000–2004 and for women from 71.9% to
85.2%. For the cohort reporting diabetes in 1980–1984,
the age-adjusted 10-year observed survival rate was 41.4%
in men and 43.7% in women Men and women reporting
diabetes fifteen years later, in the survey covering 1995–
1999, had a 10-year survival rate of 51.5% and 61.0%,
respectively.
Fifteen years survival rates have improved from about
26% to about 35% among both men and women. The
age-adjusted survival rate after 20 years of follow-up of the
1985–1989 cohort was 15.7% in men and 19.1% in
women
Discussion
There are few studies of time trends in long-term survival
among a population-based non-selected sample of sub-
jects with diabetes. In general, and as expected, diabetic
subjects have a higher mortality risk than the general pop-
ulation for the whole period 1980 to 2004. On the other
hand, survival rates have improved among diabetics in
parallel with the non-diabetic population. Women with
diabetes may even have improved their survival to a
Table 2: Relative mortality risk and 95% confidence intervals within 5 years of follow-up between subjects reporting diabetes as a 
chronic illness in the Swedish Living Conditions Survey 1980–2004 and those not reporting diabetes. 
Sex/Period Model 1 Model 2 Model 3 Model 4
Males
1980–1984 3.28 (2.72 – 3.96) 2.04 (1.69 – 2.46) 2.08 (1.73 – 2.52) 1.93 (1.60 – 2.33)
1985–1989 3.46 (2.81 – 4.26) 2.13 (1.73 – 2.63) 2.17 (1.76 – 2.68) 2.07 (1.68 – 2.55)
1990–1994 3.52 (2.80 – 4.44) 2.28 (1.81 – 2.88) 2.29 (1.82 – 2.89) 2.22 (1.76 – 2.79)
1995–1999 4.11 (3.26 – 5.17) 2.51 (2.00 – 3.17) 2.54 (2.02 – 3.20) 2.42 (1.93 – 3.05)
2000–2004 3.35 (2.60 – 4.30) 2.09 (1.63 – 2.69) 2.12 (1.65 – 2.73) 1.97 (1.53 – 2.53)
Females
1980–1984 4.52 (3.72 – 5.49) 2.47 (2.03 – 3.00) 2.51 (2.07 – 3.06) 2.39 (1.97 – 2.91)
1985–1989 5.05 (4.07 – 6.25) 2.77 (2.24 – 3.43) 2.80 (2.26 – 3.47) 2.69 (2.17 – 3.33)
1990–1994 5.35 (4.20 – 6.81) 2.43 (1.91 – 3.10) 2.49 (1.96 – 3.18) 2.44 (1.91 – 3.11)
1995–1999 2.77 (2.04 – 3.76) 1.45 (1.07 – 1.98) 1.47 (1.08 – 2.00) 1.41 (1.04 – 1.92)
2000–2004 3.52 (2.61 – 4.75) 1.90 (1.40 – 2.56) 1.92 (1.42 – 2.59) 1.80 (1.33 – 2.43)
Model 1: crude model
Model 2: controlling for age
Model 3: controlling for age, daily smoking, and socioeconomic status
Model 4: controlling for age, daily smoking, socioeconomic status, CHD and hypertension1
Non-diabetics as reference.
1. ICD-9: 401–429 Hypertension and coronary heart disease.Cardiovascular Diabetology 2008, 7:32 http://www.cardiab.com/content/7/1/32
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greater degree than non-diabetic women and thereby pos-
sibly decreased the gap.
We found that the relative mortality risk was doubled, and
that is consistent with many other published studies. It is,
however, somewhat surprising that the risk persisted and
was unchanged even after adjusting for the presence of
heart disease and hypertension, smoking habits, and
socio-economic status. The unchanged risk after adjusting
for heart disease and hypertension may be a result of dia-
betic subjects being identified and more intensively
treated for heart disease and hypertension to a higher
degree than non-diabetics. The non-diabetics may very
well be unaware of their cardiovascular risk. However, this
cannot explain why well-known risk factors such as smok-
ing and socio-economic status did not affect the relative
risk, but the impact of diabetes as an independent risk fac-
tor may well be so strong as to attenuate the effect of other
risk factors. Interestingly, the HUNT study showed no
change in cardiovascular risk after adjustment for multi-
ple risk factors [13]. The small changes in relative risks
when adjusting for socio-economic status may be a result
of the high level of equity of access to medical care in Swe-
den.
The observed 10-year survival rate for men with diabetes
has improved modestly with 10 percent units from the
cohort diagnosed in 1980–1984 as compared with the
cohorts followed since the mid and late 1990s. Still,
impressive further improvement now is discerned in the
5-year mortality in the 2000–2004 cohort. However, there
was no improvement in relative mortality in diabetic men
as compared with those without diabetes between 1980
and 2004. These finding fit in well with the recent report
from NHANES and the HUNT study [12,13]
Age-adjusted observed survival rates for men reporting diabetes as a chronic illness in the Swedish Living Conditions Survey  1980–2004 Figure 1
Age-adjusted observed survival rates for men reporting diabetes as a chronic illness in the Swedish Living Con-
ditions Survey 1980–2004. Adjusted to the age of the diabetic subjects.Cardiovascular Diabetology 2008, 7:32 http://www.cardiab.com/content/7/1/32
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On the other hand, one encouraging result was the sub-
stantial increase in 5- and 10-year survival rate for women
with diabetes, 13 and 17 percent units, respectively, which
primarily occurred in 1990s and was also discernible,
although not as impressive, in the latest cohort. The rela-
tive mortality risk for diabetic women during the time
period 1995–1999 was only 41 percent higher than in
non-diabetic women. The higher risk noted in the period
thereafter (although far lower than at baseline) must raise
the possibility of a spurious finding, but in the light of the
survival curves a more beneficial development in women
than in men is likely. Our findings, thus, are at odds with
NHANES' data where no decrease at all in mortality rates
of diabetic women was found between 1971 and 2000
[12]. On the other hand, the Norwegian HUNT study
noted similar descreases in cardiovascular mortality in
women with or without diabetes on long term follow up
of two cohorts initiated 1985 and 1996 [13].
A Canadian study showed a 25% reduction in diabetics'
mortality between 1995 and 2005 [15]. A Finnish study
showed that diabetes survival during the 1990s depended
on socio-economic differences, while survival was inde-
pendent of socio-economic status in the 1980s [16]. In
general, diabetic subjects in lower socio-economic groups
have poorer metabolic control, report more complica-
Age-adjusted observed survival rates for women reporting diabetes as a chronic illness in the Swedish Living Conditions Survey  1980–2004 Figure 2
Age-adjusted observed survival rates for women reporting diabetes as a chronic illness in the Swedish Living 
Conditions Survey 1980–2004. Adjusted to the age of the diabetic subjects.Cardiovascular Diabetology 2008, 7:32 http://www.cardiab.com/content/7/1/32
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tions, and have lower survival rates than diabetics in
higher socio-economic groups [16-18].
Improved survival of Swedish diabetics is most probably
the effects of significant changes in treatment since the
early 1980s with focus on cardiovascular prevention. Most
prominent is the aggressive treatment of hypertension,
especially with ACE inhibitors [19,20] and more recently,
with lipid-lowering statins [21,22]. The introduction of
thrombolysis following acute myocardial infarction also
gave impressive reductions in the mortality of patients
with diabetes. Diabetic patients after their first acute myo-
cardial infarction have as miserable a prognosis as that of
non-diabetic patients after a recurrent infarction [23].
That led to the practice of physicians adopting a strategy
of secondary prevention, treating supposed IHD in dia-
betic patients before overt symptoms appeared. Efforts to
achieve improvement in glucose balance are difficult to
assess and their effect on survival is less proven as high-
lighted by the recent results from the ADVANCE and
ACCORD studies [24,25]
Thus, evidence for the success of cardiovascular preven-
tion in diabetic patients accumulated over a period of
time, and was probably not extensively implemented in
primary care (where almost all Type 2 diabetic patients are
treated in Sweden) until the latter half of the 1990s. The
full impact of these measures is therefore probably not yet
appreciated.
A crucial question is whether diabetics have the same
decrease in the incidence and mortality in cardiovascular
disease as the general population and whether similar
gender differences in trends are noted. Such findings
would strongly support our data. The improved survival
for women with diabetes during the late 1990s is sup-
ported by mortality data from an independent source, the
Cause of Death Register [9]. In a report from the Northern
Sweden MONICA study, subjects with diabetes did not
reduce the incidence of myocardial infarction as com-
pared to non-diabetic subjects between 1989 and 2000,
although the improvement in case-fatality did not differ
significantly between groups [26]. Women with diabetes
had a tendency towards decreasing incidence and mortal-
ity in first-infarction, although non-significantly. A simi-
lar analysis of stroke incidence and survival from the same
MONICA centre showed that women with diabetes
decreased their risk of stroke, relative to non-diabetics, but
diabetic men did not [27]. Mortality rates improved to a
similar extent in both men and women with diabetes and
in parallel to non-diabetics. These data support both our
findings of decreasing mortality among all diabetics and
that of different time trends for men and women with dia-
betes.
Then why have male diabetics not experienced the same
decrease in mortality? One hypothesis is that women
comply to a larger extent than men with a doctor's advice.
However, one American study did not find any gender dif-
ferences in care adherence between men patients and
women patients with diabetes [28]. Further, a Swedish
study showed that there is no gender difference in the
level of glycemic control, although diabetic women visit
outpatient clinics more frequently than diabetic men.
That would give the women a greater opportunity to vig-
orously treat high blood pressure and cholesterol levels
[29]. The more frequent contact of women with health
care in general may result in diabetes being diagnosed at
an earlier and milder stage in women than in men, giving
higher survival rates. Differences in smoking rates may
explain some of the gender differences; up to recent years
we found that female diabetics smoke much less than
male diabetics.
Some factors must be considered when considering the
conclusions that we have drawn. One limitation lies in the
identification of subjects. The study group consists of
those who either report diabetes as a chronic disease or
Table 3: Age-adjusted observed survival rates (%) for males and females reporting diabetes as a chronic illness in the Swedish Living 
Conditions Survey 1980–2004. 
Sex/Follow-up 1980–1984 1985–1989 1990–1994 1995–1999 2000–2004
Males
5 years 68.4 69.2 71.3 73.9 80.4
10 years 41.4 46.6 51.0 51.5
15 years 26.0 30.3 34.5
20 years 14.9 15.7
Females
5 years 71.9 72.3 75.5 86.4 85.2
10 years 43.7 46.9 50.3 61.0
15 years 26.6 29.8 35.2
20 years 15.8 19.1
Adjusted to the age of the survey population.Cardiovascular Diabetology 2008, 7:32 http://www.cardiab.com/content/7/1/32
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who report they are treated with diabetes drugs. This
means that the control group contains some undiagnosed
cases of diabetes as no sampling for plasma glucose was
done. Another factor concerns the type of diabetes from
which a subject suffers. We have not been able to differen-
tiate between Type 1 and Type 2 diabetes, nor do we know
the ages at diagnosis. The duration of the disease has a
clear effect on survival. On the other hand, the statistical
surveys are based on random samples of the population,
and there are no indications that the median age at diag-
nosis has changed significantly over time. Further, we
have adjusted the results for the age of the subjects. A
minor drawback of our design is that subjects with diabe-
tes below 40 years of age are not included but our data are
valid for the vast majority of Swedish diabetic subjects.
This study should be followed up by at least two meas-
ures. Firstly, more studies are needed in order to confirm
or refute the tendency to increased survival of women
with diabetes. Secondly, the somewhat discouraging
results for men show that clinicians and general practi-
tioners must intensify their efforts to improve the evi-
dence-based primary and secondary preventive measures
for patients with diabetes. They must also intensify their
efforts to increase the adherence of patients to treatment
regimens.
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